BV Study
- Conditions
- Urological and Genital DiseasesBacterial vaginosis
- Registration Number
- PACTR201804003327269
- Lead Sponsor
- Perinatal HIV Research Unit
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 39
Females.
18-40 years.
Pre-menopausal on menstrual history.
Read and understand English.
Provide voluntary informed consent.
HIV-negative.
Intact genital tract.
Use Depot Medroxyprogesterone Acetate or norethisterone enanthate injectable contraception for at least 7 days by visit 1 (day 0)
Willing to receive HIV testing and counselling
Positive for pregnancy test or breastfeeding at study entry.
Infected with C. trachomatis or T. vaginalis.
History of abnormality on Pap test.
Currently using oral contraceptive.
Menstruating on enrollment.
Did not have sexual debut.
Treated with antibiotics within eight weeks of study enrollment.
Using oral or vaginal probiotic capsules within eight weeks of enrollment in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method